WDR5 WIN site inhibitor C3

CAS No. ——

WDR5 WIN site inhibitor C3( —— )

Catalog No. M17064 CAS No. ——

WDR5 WIN site inhibitor C3 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 1.3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    WDR5 WIN site inhibitor C3
  • Note
    Research use only, not for human use.
  • Brief Description
    WDR5 WIN site inhibitor C3 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 1.3 nM.
  • Description
    WDR5 WIN site inhibitor C3 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 1.3 nM; inhibits leukemia cell lines in vitro (MV4:11 cell GI50=6.67 uM), rapidly displace WDR5 from chromatin and decrease the expression of associated genes, causing translational inhibition, nucleolar stress, and p53 induction.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    HMTase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    386.427
  • Molecular Formula
    C20H23FN4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    3-(((4,5-dihydro-1H-imidazol-2-yl)amino)methyl)-N-(3,5-dimethoxybenzyl)-4-fluorobenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Aho ER, et al. Cell Rep. 2019 Mar 12;26(11):2916-2928.e13.
molnova catalog
related products
  • WDR5-0103

    A potent MLL1-WDR5 interaction inhibitor with IC50 of 26.4 nM in competitive binding assay.

  • MS012

    MS012 is a potent and selective inhibitor of G9a-Like Protein (GLP) lysine methyltransferase with IC50 of 7 nM.

  • HLCL-61 hydrochlorid...

    A novel potent and selective protein arginine methyltransferase PRMT5 inhibitor.